BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31078431)

  • 1. Mechanisms of Genomic Instability in Breast Cancer.
    Duijf PHG; Nanayakkara D; Nones K; Srihari S; Kalimutho M; Khanna KK
    Trends Mol Med; 2019 Jul; 25(7):595-611. PubMed ID: 31078431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells.
    Bower JJ; Vance LD; Psioda M; Smith-Roe SL; Simpson DA; Ibrahim JG; Hoadley KA; Perou CM; Kaufmann WK
    NPJ Breast Cancer; 2017; 3():9. PubMed ID: 28649649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer.
    Naik A; Lattab B; Qasem H; Decock J
    Mol Ther Oncol; 2024 Mar; 32(1):200768. PubMed ID: 38596293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Breast Cancer in Women.
    Coughlin SS
    Adv Exp Med Biol; 2019; 1152():9-29. PubMed ID: 31456177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer: Current Perspectives on the Disease Status.
    Fahad Ullah M
    Adv Exp Med Biol; 2019; 1152():51-64. PubMed ID: 31456179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy and Breast Cancer: Pathways to Understand Risk and Prevention.
    Slepicka PF; Cyrill SL; Dos Santos CO
    Trends Mol Med; 2019 Oct; 25(10):866-881. PubMed ID: 31383623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease.
    Thomas M; Kelly ED; Abraham J; Kruse M
    Semin Oncol; 2019 Apr; 46(2):121-132. PubMed ID: 31239068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of breast cancer: management strategies and risk-reducing surgery.
    Balasubramanian R; Rolph R; Morgan C; Hamed H
    Br J Hosp Med (Lond); 2019 Dec; 80(12):720-725. PubMed ID: 31822191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets.
    Liang Y; Zhang H; Song X; Yang Q
    Semin Cancer Biol; 2020 Feb; 60():14-27. PubMed ID: 31421262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electromagnetic Fields, Genomic Instability and Cancer: A Systems Biological View.
    Naarala J; Kolehmainen M; Juutilainen J
    Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31242701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology and diagnosis of breast cancer].
    Budny A; Starosławska E; Budny B; Wójcik R; Hys M; Kozłowski P; Budny W; Brodzik A; Burdan F
    Pol Merkur Lekarski; 2019 May; 46(275):195-204. PubMed ID: 31152530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer.
    Bao S; Zhao H; Yuan J; Fan D; Zhang Z; Su J; Zhou M
    Brief Bioinform; 2020 Sep; 21(5):1742-1755. PubMed ID: 31665214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EZH2-PHACTR2-AS1-Ribosome Axis induces Genomic Instability and Promotes Growth and Metastasis in Breast Cancer.
    Chu W; Zhang X; Qi L; Fu Y; Wang P; Zhao W; Du J; Zhang J; Zhan J; Wang Y; Zhu WG; Yu Y; Zhang H
    Cancer Res; 2020 Jul; 80(13):2737-2750. PubMed ID: 32312833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways.
    Das PK; Rakib MA; Khanam JA; Pillai S; Islam F
    Curr Stem Cell Res Ther; 2019; 14(8):669-682. PubMed ID: 31808385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel's Mechanistic and Clinical Effects on Breast Cancer.
    Abu Samaan TM; Samec M; Liskova A; Kubatka P; Büsselberg D
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31783552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hormone and breast cancer].
    Gompel A
    Presse Med; 2019 Oct; 48(10):1085-1091. PubMed ID: 31662219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical ubiquitin-binding protein SHARPIN promotes breast cancer progression.
    Tian Z; Tang J; Yang Q; Li X; Zhu J; Wu G
    Biomed Pharmacother; 2019 Nov; 119():109414. PubMed ID: 31518875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention of Breast Cancer With Vitamins and Micronutrients: A Concise Review.
    Mokbel K; Mokbel K
    In Vivo; 2019; 33(4):983-997. PubMed ID: 31280187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving insights: how DNA repair pathways impact cancer evolution.
    Zhou J; Zhou XA; Zhang N; Wang J
    Cancer Biol Med; 2020 Nov; 17(4):805-827. PubMed ID: 33299637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decade of clinical development of PARP inhibitors in perspective.
    Mateo J; Lord CJ; Serra V; Tutt A; Balmaña J; Castroviejo-Bermejo M; Cruz C; Oaknin A; Kaye SB; de Bono JS
    Ann Oncol; 2019 Sep; 30(9):1437-1447. PubMed ID: 31218365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.